StockData
XTL Biopharmaceuticals Ltd logo

XTL Biopharmaceuticals Ltd (XTLB) stock

XTLBNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Jun 30, 2026Score 0/30
$1.54−0.08 (-4.94%)

Close on Nov 18, 2026Market cap $14.57MP/E –Yield –

XTL Biopharmaceuticals net income

Net income is the profit left for shareholders after every expense, interest and tax.

For fiscal 2015 it was $2.00K.

Annual net income

PeriodPeriod endValueChange
FY2015Dec 31, 2015$2.00K–

More XTL Biopharmaceuticals figures

See a number that looks wrong?